| Cat. No. |
Product Name |
Information |
| PC-27211 |
MEISi-3
MEIS2 inhibitor
|
MEISi-3 is a small molecule MEIS2 inhibitor targeting MEIS2 proteins effectively along with MEIS1, exhibits potent growth inhibition with IC50 of 0.1 μM in SK-BR-3 cells. |
| PC-27204 |
Semax
Neuroactive peptide
|
Semax is a BBB-penetrable, synthetic peptide analog of Adrenocorticotropic hormone (ACTH) (4-10), can form stable complexes with Cu2+, has immunomodulatory, nootropic and neuroprotective activities. |
| PC-27197 |
DHPS inhibitor GC7
DHPS inhibitor
|
GC7 (N1-guanyl-1,7-diaminoheptane) is a high affinity, effective deoxyhypusine synthase (DHPS) inhibitor with Ki of 10 nM, inhibits spermidine-dependent hypusine-eIF5A activation. |
| PC-27196 |
FPTP
NEK9 inhibitor
|
FPTP is a pharmacological small-molecule NEK9 inhibitor with SPR KD of 3.64 uM, inhibits viability of Huh-7 and Hep3b cells with IC50 of 18.7 uM and 22.8 uM. |
| PC-27195 |
MIPO
NEK9 inhibitor
|
MIPO is a pharmacological small-molecule NEK9 inhibitor with SPR KD of 7.72 uM, inhibits viability of Huh-7 and Hep3b cells with IC50 of 18.8 uM and 19.7 uM. |
| PC-27194 |
ICCB280
C/EBPalpha agonist
|
ICCB280 is a specific small molecule C/EBPalpha (C/EBPα) agonist, induces myeloid differentiation of leukemia cell lines by increasing expression of C/EBPα and C/EBPε, and decreasing expression of c-Myc. |
| PC-27187 |
LRI-305
LIF antagonist
|
LRI-305 (LRI305) is a selective antagonist of Leukemia Inhibitory Factor (LIF) receptor (LIFR), effectively inhibits LIF/LIFR interaction with with IC50 of 0.86 uM in Alpha Screen assays. |
| PC-27168 |
Maresin 1
Macrophage proresolving mediator
|
Maresin-1 (Maresin 1, MaR1) is a potent anti-inflammatory and proresolving mediator biosynthesized by macrophages (MΦs), enhances phagocytosis. |
| PC-27147 |
Zinc protoporphyrin IX
HO-1 inhibitor
|
ZnPP-9 (Zinc protoporphyrin IX, ZnPP-9, Zinc protoporphyrin-9) is an orally active and competitive heme oxygenase-1 (HO-1) inhibitor, regulates expression of HO-1 at the transcriptional level, demonstrates potent antitumor effects. |
| PC-27141 |
STK33-IN-1
STK33 inhibitor
|
STK33-IN-1 is a highly potent serine/threonine kinase STK33 inhibitor with IC50 of 7 nM, inhibitsa number of other kinases in addition to STK33. |
| PC-27139 |
EYA2 degrader EC21
EYA2 degrader
|
EYA2 degrader EC21 is a bifunctional small molecule EYA2 degrader via CDK6 recruitment, enhances the interaction between CDK6 and EYA2, thereby promoting EYA2 degradation, disrupts DNA damage repair pathways and significantly suppresses breast cancer cell proliferation. |
| PC-27133 |
PT-13
Tau disaggregant
|
PT-13 is a brain-penetrant small-molecule tau disaggregant inhibiting tau seeding and disaggregating fibrils, reduces tau pathology while preserving behavioral function, proteasome capacity, and synaptic integrity in tauopathy mouse model. |
